SUVEN
Suven Life Sciences
Each stock's 10,000-path forecast, rendered as light.
Suven Life Sciences (SUVEN) Stock Analysis & Case Study
Is SUVEN a good buy? The data-driven verdict.
on the numbers it mixed signals, a Downstox Snapshot Score of 53/100.
On the numbers, Suven Life Sciences (SUVEN) mixed signals, a Downstox Snapshot Score of 53/100, weighing a 72% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
SUVEN share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of SUVEN history (51%/yr drift, 58%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SUVEN 2027 | ₹175 | ₹378 | ₹798 | +41% |
| SUVEN 2028 | ₹179 | ₹530 | ₹1,547 | +98% |
| SUVEN 2029 | ₹204 | ₹749 | ₹2,772 | +179% |
| SUVEN 2030 | ₹236 | ₹1,061 | ₹4,666 | +296% |
| SUVEN 2031 | ₹284 | ₹1,496 | ₹7,888 | +458% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SUVEN goes up, or doubles?
The bull case for SUVEN
- A 10,000-path probability model puts a 72% chance the price is higher in a year, with a median target of ₹378 (+41%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹2,772.
The bear case & risks
- High historical volatility (58%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹204.
SUVEN volatility & expected range, how bumpy is the ride?
Over the last 2.0 years SUVEN compounded at 51%/year with annualized volatility of 58%. That volatility implies a 1-year 80% range of ₹175–₹798, the honest backbone behind any single price target.
SUVEN price forecast, the full 60-month probability fan
SUVEN price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SUVEN hits common targets within the simulated horizon?
Full multi-horizon detail on the SUVEN price target & forecast page.
SUVEN MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy SUVEN with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 42.0% | 2.4× |
| ZerodhaCHEAPEST | 42.0% | 2.4× |
| Dhan | 64.0% | 1.6× |
Compare every broker on the SUVEN MTF page.
SUVEN vs peers,sector comparison
About Suven Life Sciences: sector, index & market-cap context
Suven Life Sciences (SUVEN) is an NSE-listed company.
How the SUVEN Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Suven Life Sciences's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SUVEN analysis, FAQs
Is Suven Life Sciences (SUVEN) a good buy?
On the numbers, Suven Life Sciences (SUVEN) mixed signals, a Downstox Snapshot Score of 53/100, weighing a 72% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SUVEN overvalued or undervalued?
Valuation ratios for SUVEN are tracked live on Downstox.
What is the SUVEN share price target for 2031?
SUVEN's probability-weighted 2031 median target is ₹1,496, with an 80% range of ₹284–₹7,888 (10,000-path Monte-Carlo).
What is the probability SUVEN doubles in 5 years?
The modelled probability of SUVEN reaching ₹536 (2×) within 5 years is 79%.
What is the bull case for SUVEN?
A 10,000-path probability model puts a 72% chance the price is higher in a year, with a median target of ₹378 (+41%).
What are the risks in SUVEN?
High historical volatility (58%/yr) means a wide, bumpy range of outcomes, size positions accordingly.